These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17973891)

  • 1. Epidermodysplasia verruciformis: unsuccessful therapeutic approach with imiquimod.
    Janssen K; Lucker GP; Houwing RH; van Rijssel R
    Int J Dermatol; 2007 Nov; 46 Suppl 3():45-7. PubMed ID: 17973891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: a therapeutic challenge.
    Baskan EB; Tunali S; Adim SB; Turan A; Toker S
    J Dermatolog Treat; 2006; 17(3):179-83. PubMed ID: 16854762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Imiquimod Resistant Epidermodysplasia Verruciformis With Ingenol Mebutate.
    Kim C; Hashemi P; Caglia M; Shulman K
    J Drugs Dermatol; 2016 Mar; 15(3):350-2. PubMed ID: 26954321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream].
    Heratizadeh A; Völker B; Kupsch E; Wichmann K; Kapp A; Werfel T
    Hautarzt; 2010 Dec; 61(12):1052-5. PubMed ID: 20824263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
    Yoshida R; Kato T; Kawase M; Honda M; Mitsuishi T
    BMC Dermatol; 2014 Jul; 14():12. PubMed ID: 25048734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of a patient with epidermodysplasia verruciformis carrying a novel EVER2 mutation with imiquimod.
    Berthelot C; Dickerson MC; Rady P; He Q; Niroomand F; Tyring SK; Pandya AG
    J Am Acad Dermatol; 2007 May; 56(5):882-6. PubMed ID: 17368633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained clinical resolution of acquired epidermodysplasia verruciformis in an immunocompromised patient after discontinuation of oral acitretin with topical imiquimod.
    Nijhawan RI; Osei-Tutu A; Hugh JM
    J Drugs Dermatol; 2013 Mar; 12(3):348-9. PubMed ID: 23545921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired epidermodysplasia verruciformis in a child with atopic dermatitis.
    Fernandez KH; Rady P; Tyring S; Stone MS
    Pediatr Dermatol; 2014; 31(3):400-2. PubMed ID: 22938530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired epidermodysplasia verruciformis in an HIV-positive patient.
    Lau C; Acharya S; Arumainayagam JT; Kasparis C; Dhesi I
    Int J STD AIDS; 2016 Oct; 27(11):1023-5. PubMed ID: 26516132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the evidence for effective treatments of acquired epidermodysplasia verruciformis in HIV-infected patients?
    Lee KC; Risser J; Bercovitch L
    Arch Dermatol; 2010 Aug; 146(8):903-5. PubMed ID: 20713825
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidermodysplasia verruciformis: An early and unusual presentation.
    Emsen IM; Kabalar ME
    Can J Plast Surg; 2010; 18(1):21-4. PubMed ID: 21358870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired epidermodysplasia verruciformis in a patient with congenital HIV infection.
    Castro-Perez GA; Sorin I; Bravo AI; Mazzuoccolo LD
    Actas Dermosifiliogr; 2013 Oct; 104(8):731-3. PubMed ID: 24067256
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidermodysplasia verruciformis and human papilloma virus.
    Gewirtzman A; Bartlett B; Tyring S
    Curr Opin Infect Dis; 2008 Apr; 21(2):141-6. PubMed ID: 18317036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
    Moore S; Rady P; Tyring S
    Int J Dermatol; 2022 Nov; 61(11):1325-1335. PubMed ID: 34403500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired epidermodysplasia verruciformis.
    Rogers HD; Macgregor JL; Nord KM; Tyring S; Rady P; Engler DE; Grossman ME
    J Am Acad Dermatol; 2009 Feb; 60(2):315-20. PubMed ID: 19150275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between epidermodysplasia verruciformis-associated human papillomavirus DNA in plucked eyebrow hair and solar keratoses.
    Boxman IL; Russell A; Mulder LH; Bavinck JN; ter Schegget J; Green A;
    J Invest Dermatol; 2001 Nov; 117(5):1108-12. PubMed ID: 11710920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of a variety of epidermodysplasia verruciformis-associated human papillomaviruses in psoriatic skin of patients treated or not treated with PUVA.
    Weissenborn SJ; Höpfl R; Weber F; Smola H; Pfister HJ; Fuchs PG
    J Invest Dermatol; 1999 Jul; 113(1):122-6. PubMed ID: 10417630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon alfa-2a.
    Anadolu R; Oskay T; Erdem C; Boyvat A; Terzi E; Gürgey E
    J Am Acad Dermatol; 2001 Aug; 45(2):296-9. PubMed ID: 11464195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.
    Maor D; Brennand S; Goh MS; Fahey V; Tabrizi SN; Chong AH
    Australas J Dermatol; 2018 May; 59(2):147-148. PubMed ID: 28718200
    [No Abstract]   [Full Text] [Related]  

  • 20. Seborrheic Keratosis-like lesions in patients with epidermodysplasia verruciformis.
    Roncalli de Oliveira W; Neto CF; Rady PL; Tyring SK
    J Dermatol; 2003 Jan; 30(1):48-53. PubMed ID: 12598709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.